ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 903

Increased Expression of CCN4/WISP1 in Osteoarthritic Articular Cartilage Is Epigenetically Regulated and Disrupts Cartilage Homeostasis

Martijn H. van den Bosch1, Yolande F. Ramos2, Wouter den Hollander2, Nils Bömer2, Rob G. Nelissen3, Judith V. Bovée4, Peter L. van Lent1, Arjen B. Blom1, Peter M. van der Kraan1 and Ingrid Meulenbelt2, 1Experimental Rheumatology, Radboud university medical center, Nijmegen, Netherlands, 2Department of Molecular Epidemiology, Leiden University Medical Center, Leiden, Netherlands, 3Department of Orthopedics, Leiden University Medical Center, Leiden, Netherlands, 4Department of Pathology, Leiden University Medical Center, Leiden, Netherlands

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: cartilage, Epigenetics, methylation and osteoarthritis, WNT Signaling

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 5, 2017

Title: Biology and Pathology of Bone and Joint

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: Previously, we described increased expression of Wnt-1-induced signaling protein 1 (Wisp1) in murine synovium and cartilage after induction of experimental osteoarthritis (OA) models. WISP1 is a downstream target of canonical Wnt signaling, which has been shown to play a pivotal role in the etiopathology of OA. In agreement with this, we have observed increased breakdown of the articular cartilage after overexpression of Wisp1 in naïve mouse knee joints, whereas Wisp1-/- mice revealed decreased cartilage degeneration in three independent experimental OA models compared to wild type controls. Together, these data indicate a direct correlation between Wisp1 and OA in mice. In the current study we set out to characterize the relation between expression of WISP1and human OA.

Methods: Articular cartilage from preserved and degenerated OA areas was collected from 39 Caucasian end-stage OA patients. Cartilage from non-OA-diagnosed individuals was collected after femoral neck fractures. Cartilage degeneration was classified according to the Mankin scoring system. DNA was isolated to determine correlation between WISP1 expression and methylation profiles using Generalized Linear Mixed Model (GLMM). RNA expression levels were determined with microarray analysis and RNA sequencing. Immunohistochemical staining was used to determine WISP1 protein expression. Recombinant WISP1 was added to human chondrocyte microparticles, and cartilage extracellular matrix deposition was determined by measuring cartilage microparticle size and Safranin O/Fast Green staining.

Results:

We observed increased WISP1 expression in cartilage of OA patients compared to non-OA-diagnosed controls. Moreover, within OA patients, both WISP1 mRNA and protein expression were significantly increased in OA-affected cartilage compared to preserved regions of the same joint, and WISP1 expression significantly correlated with Mankin score. Interestingly, we found that positional CpG dinucleotides were hypomethylated in cartilage of OA-affected areas as compared to unaffected areas from the same joint, which correlated with increased RNA expression as determined with both microarray analysis and RNA sequencing analysis. Of note, methylation levels of a CpG affecting WISP1 transcription were found to highly significantly correlate to a single nucleotide polymorphism (SNP) at the WISP1 locus. Next, to investigate effects of increased WISP1 levels on chondrocyte microparticles, we added human recombinant WISP1. This resulted in a significantly decreased deposition of cartilage extracellular matrix as reflected by decreased microparticle circumference, and a strongly decreased proteoglycan content, suggesting that increased WISP1 levels are detrimental to cartilage.

Conclusion:

The expression of WISP1 is increased in OA-affected as compared to preserved articular cartilage. This increased expression is inversely correlated with methylation levels of a positional CpG, which was found to be under the influence of a SNP at the WISP1 locus. Together, our results suggest that tight regulation of WISP1 expression via methylation is essential to maintain cartilage homeostasis.


Disclosure: M. H. van den Bosch, None; Y. F. Ramos, None; W. den Hollander, None; N. Bömer, None; R. G. Nelissen, None; J. V. Bovée, None; P. L. van Lent, None; A. B. Blom, None; P. M. van der Kraan, Contract research UCB, 2; I. Meulenbelt, None.

To cite this abstract in AMA style:

van den Bosch MH, Ramos YF, den Hollander W, Bömer N, Nelissen RG, Bovée JV, van Lent PL, Blom AB, van der Kraan PM, Meulenbelt I. Increased Expression of CCN4/WISP1 in Osteoarthritic Articular Cartilage Is Epigenetically Regulated and Disrupts Cartilage Homeostasis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/increased-expression-of-ccn4wisp1-in-osteoarthritic-articular-cartilage-is-epigenetically-regulated-and-disrupts-cartilage-homeostasis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/increased-expression-of-ccn4wisp1-in-osteoarthritic-articular-cartilage-is-epigenetically-regulated-and-disrupts-cartilage-homeostasis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology